Home News About us Comitato scientifico Iscriviti Utenti Etica Contenuti Guida Faq Stage Contatti ☰
Logo Pharmamedix
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Fluconazolo

Diflucan, Elazor, Flukimex e altri

Bibliografia - Quali fonti bibliografiche per Fluconazolo?

1. Adverse Drug Reaction Bulletin, 2012

2. Aleck K.A., Bartley D.L., Am. J. Med. Genet., 1997, 72 (3), 253.

3. Allison E.J. Jr. et al., Eur. J. Emerg. Med., 2002, 9 (2), 175.

4. Ahonen J. et al., Eur. J. Clin. Pharmacol., 1997, 51 (5), 415.

5. Ahonen J. et al., Acta Anaesthesiol. Scand., 1999, 43 (5), 509.

6. Amsden G.W. et al., Clin. Drug Invest., 2000, 20 (2), 135.

7. Apseloff G. et al., J. Clin. Pharmacol., 1991, 31, 358.

8. Babalola C.P. et al., J. Clin. Pharm. Ther., 2009, 34 (6), 677.

9. Beecker J., Colantonio S., CMAJ, 2012, 184 (6), 675.

10. Benedix F. et al., Acta Derm. Venereol., 2008, 88 (5), 491.

11. Black D.J. et al., Drug Metab. Dispos., 1996, 24 (4), 422.

12. Blum R.A. et al., Pharmacotherapy, 1999, 19 (4 Pt 2), 79S.

13. Cadle R.M. et al., The Annals of Pharmacotherapy, 1994, 28 (2, 191.

14. Calonghi G., Gabbi E., Inf. sui Farmaci, 1989, XIII (3), 255.

15. Canafax D.M. et al., Transplantation, 1991, 51, 1014.

16. Cato A et al., Drug Metab. Dispos., 1997, 25 (9), 1104.

17. Cheitlin M.D. et al., J. Am. Coll. Cardiol., 1999, 33 (1), 273.

18. Cob M.N. et al., Clin. Pharmacol. Ther., 1998, 63 (6), 655.

19. Cooper K.J. et al., Eur. J. Clin. Pharmacol., 2002, 58 (8), 527.

20. Crussell-Porter L.L., Arch. Intern. Med., 1993, 153, 102.

21. Damle B. et al., Antimicrob. Agents Chemother., 2011, 55 (11), 5172.

22. Dastghaib L. et al., J. Dermatolog. Treat., 2005, 16 (1), 43.

23. Debruyne D., Clin. Pharmacokinet., 1997, 33 (1), 52.

24. Dismukes W.E., Ann. Intern. Med., 1988, 109 (3), 177.

25. Dugal H.S., Gen. Hosp. Psychiatry, 2003, 25 (4), 297.

26. EMEA, Diflucan - Article 30 referral - Assessment Report, 2 febbraio disponibile online http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Diflucan/human_referral_000278.jsp&mid=WC0b01ac05805c516f

27. EMEA, Diflucan - Article 30 referral - Annex III, 2 febbraio dispnibile online http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Diflucan/human_referral_000278.jsp&mid=WC0b01ac05805c516f.

28. Ernst E.J. et al., Diagn. Microbiol. Infect. Dis., 1998, 32 (3), 205.

29. Foster K.W. et al., J. Am. Acad. Dermatol., 2005, 53 (5), 798.

30. Gondo H. et al., Bone Marrow Transplant., 2000, 26 (11), 1255.

31. Grant S.M., Clissold S.P., Drugs, 1990, 39, 877.

32. Greenblatt D.J. et al., Clin. Pharmacol. Ther., 2006, 79 (1), 125.

33. Hallberg P. et al., Eur. J. Clin. Pharmacol., 2006, 62 (6), 491.

34. Harnicar S. et al., J. Oncol. Pharm. Pract., 2009, 15 (3), 175.

35. Hazin R. et al., J. Natl. Med. Assoc., 2008, 100 (4), 444.

36. Hilbert J. et al., Obstet. Gynecol., 2001, 98 (2), 218.

37. Hitchcock C.A. et al., Antimicrob. Agents Chemother., 1993, Sep. 37, 1962.

38. Hynninen V.V. et al., Antimicrob. Agents Chemother., 2006, 50 (6), 1967.

39. Holmes D. et al., Case Rep. Oncol. Med., 2012, 2012, 313057.

40. Honig P.K. et al., Clin. Pharmacol. Ther., 1993, 53 (6), 630.

41. JAMA ed. it., 1990, 2, 740.

42. Jordan M.K. et al., Antimicrob. Agents Chemother., 2000, 44 (8), 2170.

43. Kahri J. et al., Eur. J. Clin. Pharmacol., 2005, 60 (12), 905.

44. Kakuda T.N. et al., Clin. Pharmacokinet., 2011, 50 (1), 25.

45. Kantola T. et al., Eur. J. Clin. Pharmacol., 2000, 56 (3), 225.

46. Kaukonen K.M. et al., Eur. J. Clin. Pharmacol., 1998, 53 (6), 445.

47. Kim C.Y. et al., Ann. Dermatol., 2011, 23 Suppl. 1, S1.

48. Konishi H. et al., Eur. J. Clin. Pharmacol., 1994, 46 (4), 309.

49. Koks C.H. et al., Br. J. Clin. Pharmacol., 2001, 51 (6), 631.

50. Lane M.A. et al., J. Clin. Pharm. Ther., 2012, 37 (2), 157.

51. Lee B. et al., Pediatr. Infect. Dis. J., 1992, 11 (12), 1062.

52. Lazar J.D., Rev. Infect. Dis., 1990, 12 (Suppl. 3), S327.

53. Lopez-Rangel E. et al., Birth Defects Res. A Clin. Mol. Teratol., 2005, 73 (11), 919

54. Marino M.R., Vachharajani N.N., Clin. Pharmacokinet., 2001, 40 (8), 605.

55. Marr K.A. et al., Blood, 2004, 103 (4), 1557.

56. Mazziotti F. et al., Minerva Ginecol., 1992, 44, 653.

57. Med. Lett., ed. it., 1994, 7, 27.

58. Michalets E.L., Williams C.R., Clin. Pharmacokinet., 2000, 39 (1), 49.

59. Mihara A. et al., Eur. J. Clin. Pharmacol., 2008, 64 (1), 89.

60. Mitchell A.S., Holland J.T., BMJ, 1989, 268 (6683), 1315

61. Mootha V.V. et al., 2002, 120 (1), 94.

62. Nair D.R., Morris H.H., Ann. Pharmacother., 1999, 33 (7-8), 790.

63. Nicolau D.P. et al., Ann. Pharmacother., 1995, 29 (10), 994.

64. Newberry D.L. et al., Clin. Infect. Dis., 1997, 24 (2), 270.

65. Noorgard M. et al., J. Antimicrob. Chemother., 2008, 62 (1), 172.

66. Palkama V.J. et al., Anest. Analg., 1998, 87 (1), 190.

67. Pea F. et al., Ann. Pharmacother., 2008, 42 (11), 1711.

68. Pursley T.J. et al., Clin. Infect. Dis., 1996, 22 (2), 336.

69. Rees T. Phillips R., Intern. J. Gynecol. Obstet., 1992, Suppl. 37, 33.

70. Robinson R.F. et al., Ann. Pharmacother., 2000, 34 (12), 1406.

71. Saari T.I. et al., Eur. J. Clin. Pharmacol., 2008, 64 (1), 25.

72. Sahai J. et al., J. Infect. Dis., 1994, 169 (5), 1103.

73. Sadaba B. et al., Transplant. Proc., 2004, 36 (10), 3226.

74. Santos J.R. et al., Antimicrob. Agents Chemother., 2012, 56 (5), 2553.

75. Scheda prodotto Diflucan, 2009.

76. Schwartz E.L. et al., Biochem. Pharmacol., 1995, 50 (7), 923.

77. Schelleman H. et al., Clin. Pharmacol. Ther., 2008, 84 (5), 581.

78. Shaukat A. et al., Ann. Pharmacother., 2003, 37 (7-8), 1032.

79. Sinai J. et al., J. Infect. Dis., 1994, 169, 1103.

80. Sobel J.D., Int. J. Gyaecol. Obstet., 1992, 37 Suppl.1, 17.

81. St Clair K., Maguire J.D., Int. J. STD AIDS, 2012, 23 (5), 371.

82. Stergiopoulou T. et al., J. Antimicrob. Chemother., 2009, 63 (2), 343.

83. Tarumi Y. et al., J. Pain Symptom Manage., 2002, 23 (2), 148.

84. Tavallaee M., Rad M.M., J. Med. Case Rep., 2009, 6 (3), 7368.

85. Terrell C.L., Mayo Clin. Proc., 1999, 74 (1), 78.

86. Teusink A.C. et al., Pediatr. Hematol. Oncol., 2012, 29 (1), 62.

87. Thi L. et al., Consult. Pharm., 2009, 24 (3), 227.

88. Tholakanahalli V.N. et al., Ann. Pharmacother., 2001, 35, 432.

89. Tiao G.M. et al., Clin. Transplant., 1999, 13 (1 Pt 1), 62.

90. Tirkkonen T. et al., J. Intern. Med., 2010, 268 (4), 359.

91. Trapnell C.B. et al., Ann. Intern. Med., 1996, 124 (6), 573.

92. Tucker R.M. et al., Clin. Infect. Dis., 1992, 14 (1), 165.

93. Upton A. et al., Biol. Blood Marrow Tramsplant., 2007, 13 (7), 760.

94. Vahre A. et al., Br. J. Clin. Pharmacol., 1996, 41 (4), 319.

95. Vahre A. et al., Br. J. Clin. Pharmacol., 1996a, 42 (4), 465.

96. Van Heusden A.M. et al., Acta Obst. Gynecol. Scan., 1990, 69, 417.

97. Vanier K.L. et al., J. Pediatr. Hematol. Oncol., 2003, 25 (5), 403.

98. Venkatakrishnan K. et al., Clin. Pharmacokinet., 2000, 38 (2), 111.

99. Walling H.W., SwickB.L., J. Drug Dermatol., 2010, 9 (8), 1025.

100. Wassmann S. et al., Ann. Intern. Med., 1999, 131 (10), 797.

101. Yeates R.A., Br. J. Clin. Pharmac., 1994, 38, 77.

102. Yu D.T. et al., Pharmacoepidemiol. Drug Saf., 2005, 14 (11), 755.

103. Ziegler C., Soltz-Szots J., Sex Transm. Dis., 1994, 21 Suppl., 177.